Truncated ERG Oncoproteins from TMPRSS2-ERG Fusions Are Resistant to SPOP-Mediated Proteasome Degradation

被引:136
作者
An, Jian [1 ,2 ,3 ]
Ren, Shancheng [4 ]
Murphy, Stephen J. [5 ]
Dalangood, Sumiya [6 ]
Chang, Cunjie [6 ]
Pang, Xiaodong [7 ]
Cui, Yangyan [6 ]
Wang, Liguo [8 ]
Pan, Yunqian [1 ]
Zhang, Xiaowei [1 ]
Zhu, Yasheng [4 ]
Wang, Chenji [9 ]
Halling, Geoffrey C. [5 ]
Cheng, Liang [10 ]
Sukov, William R. [11 ]
Karnes, R. Jeffrey [2 ,5 ]
Vasmatzis, George [5 ,12 ]
Zhang, Qing [6 ]
Zhang, Jun [11 ]
Cheville, John C. [5 ,11 ]
Yan, Jun [6 ]
Sun, Yinghao [4 ]
Huang, Haojie [1 ,2 ,3 ]
机构
[1] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA
[2] Mayo Clin, Coll Med, Dept Urol, Rochester, MN 55905 USA
[3] Mayo Clin, Coll Med, Ctr Canc, Rochester, MN 55905 USA
[4] Second Mil Med Univ, Shanghai Changhai Hosp, Dept Urol, Shanghai 200433, Peoples R China
[5] Mayo Clin, Coll Med, Ctr Individualized Med, Rochester, MN 55905 USA
[6] Nanjing Univ, Model Anim Res Ctr, MOE Key Lab Model Anim Dis Study, Nanjing 210061, Jiangsu, Peoples R China
[7] Fudan Univ, Dept Phys, State Key Lab Surface Phys, Shanghai 200433, Peoples R China
[8] Mayo Clin, Coll Med, Dept Med Informat & Stat, Rochester, MN 55905 USA
[9] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China
[10] Indiana Univ Sch Med, Dept Pathol, Indianapolis, IN 46202 USA
[11] Mayo Clin, Coll Med, Dept Lab Med & Pathol, Rochester, MN 55905 USA
[12] Mayo Clin, Coll Med, Dept Mol Med, Rochester, MN 55905 USA
基金
美国国家卫生研究院; 国家教育部博士点专项基金资助; 中国国家自然科学基金;
关键词
PROSTATE-CANCER; GENE FUSIONS; ANDROGEN RECEPTOR; TRANSCRIPTION FACTOR; UBIQUITIN LIGASES; KIDNEY CANCER; MUTATIONS; PTEN; PHOSPHORYLATION; TUMORIGENESIS;
D O I
10.1016/j.molcel.2015.07.025
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
SPOP mutations and TMPRSS2-ERG rearrangements occur collectively in up to 65% of human prostate cancers. Although the two events are mutually exclusive, it is unclear whether they are functionally interrelated. Here, we demonstrate that SPOP, functioning as an E3 ubiquitin ligase substrate-binding protein, promotes ubiquitination and proteasome degradation of wild-type ERG by recognizing a degron motif at the N terminus of ERG. Prostate cancer-associated SPOP mutations abrogate the SPOP-mediated degradation function on the ERG oncoprotein. Conversely, the majority of TMPRSS2-ERG fusions encode N-terminal-truncated ERG proteins that are resistant to the SPOP-mediated degradation because of degron impairment. Our findings reveal degradation resistance as a previously uncharacterized mechanism that contributes to elevation of truncated ERG proteins in prostate cancer. They also suggest that overcoming ERG resistance to SPOP-mediated degradation represents a viable strategy for treatment of prostate cancers expressing either mutated SPOP or truncated ERG.
引用
收藏
页码:904 / 916
页数:13
相关论文
共 43 条
[1]   Destruction of Full-Length Androgen Receptor by Wild-Type SPOP, but Not Prostate-Cancer-Associated Mutants [J].
An, Jian ;
Wang, Chenji ;
Deng, Yibin ;
Yu, Long ;
Huang, Haojie .
CELL REPORTS, 2014, 6 (04) :657-669
[2]   ETV1 directs androgen metabolism and confers aggressive prostate cancer in targeted mice and patients [J].
Baena, Esther ;
Shao, Zhen ;
Linn, Douglas E. ;
Glass, Kimberly ;
Hamblen, Melanie J. ;
Fujiwara, Yuko ;
Kim, Jonghwan ;
Minh Nguyen ;
Zhang, Xin ;
Godinho, Frank J. ;
Bronson, Roderick T. ;
Mucci, Lorelei A. ;
Loda, Massimo ;
Yuan, Guo-Cheng ;
Orkin, Stuart H. ;
Li, Zhe .
GENES & DEVELOPMENT, 2013, 27 (06) :683-698
[3]   Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer [J].
Barbieri, Christopher E. ;
Baca, Sylvan C. ;
Lawrence, Michael S. ;
Demichelis, Francesca ;
Blattner, Mirjam ;
Theurillat, Jean-Philippe ;
White, Thomas A. ;
Stojanov, Petar ;
Van Allen, Eliezer ;
Stransky, Nicolas ;
Nickerson, Elizabeth ;
Chae, Sung-Suk ;
Boysen, Gunther ;
Auclair, Daniel ;
Onofrio, Robert C. ;
Park, Kyung ;
Kitabayashi, Naoki ;
MacDonald, Theresa Y. ;
Sheikh, Karen ;
Vuong, Terry ;
Guiducci, Candace ;
Cibulskis, Kristian ;
Sivachenko, Andrey ;
Carter, Scott L. ;
Saksena, Gordon ;
Voet, Douglas ;
Hussain, Wasay M. ;
Ramos, Alex H. ;
Winckler, Wendy ;
Redman, Michelle C. ;
Ardlie, Kristin ;
Tewari, Ashutosh K. ;
Mosquera, Juan Miguel ;
Rupp, Niels ;
Wild, Peter J. ;
Moch, Holger ;
Morrissey, Colm ;
Nelson, Peter S. ;
Kantoff, Philip W. ;
Gabriel, Stacey B. ;
Golub, Todd R. ;
Meyerson, Matthew ;
Lander, Eric S. ;
Getz, Gad ;
Rubin, Mark A. ;
Garraway, Levi A. .
NATURE GENETICS, 2012, 44 (06) :685-U107
[4]   The genomic complexity of primary human prostate cancer [J].
Berger, Michael F. ;
Lawrence, Michael S. ;
Demichelis, Francesca ;
Drier, Yotam ;
Cibulskis, Kristian ;
Sivachenko, Andrey Y. ;
Sboner, Andrea ;
Esgueva, Raquel ;
Pflueger, Dorothee ;
Sougnez, Carrie ;
Onofrio, Robert ;
Carter, Scott L. ;
Park, Kyung ;
Habegger, Lukas ;
Ambrogio, Lauren ;
Fennell, Timothy ;
Parkin, Melissa ;
Saksena, Gordon ;
Voet, Douglas ;
Ramos, Alex H. ;
Pugh, Trevor J. ;
Wilkinson, Jane ;
Fisher, Sheila ;
Winckler, Wendy ;
Mahan, Scott ;
Ardlie, Kristin ;
Baldwin, Jennifer ;
Simons, Jonathan W. ;
Kitabayashi, Naoki ;
MacDonald, Theresa Y. ;
Kantoff, Philip W. ;
Chin, Lynda ;
Gabriel, Stacey B. ;
Gerstein, Mark B. ;
Golub, Todd R. ;
Meyerson, Matthew ;
Tewari, Ashutosh ;
Lander, Eric S. ;
Getz, Gad ;
Rubin, Mark A. ;
Garraway, Levi A. .
NATURE, 2011, 470 (7333) :214-220
[5]   SPOP Mutations in Prostate Cancer across Demographically Diverse Patient Cohorts [J].
Blattner, Mirjam ;
Lee, Daniel J. ;
O'Reilly, Catherine ;
Park, Kyung ;
MacDonald, Theresa Y. ;
Khani, Francesca ;
Turner, Kevin R. ;
Chiu, Ya-Lin ;
Wild, Peter J. ;
Dolgalev, Igor ;
Heguy, Adriana ;
Sboner, Andrea ;
Ramazangolu, Sinan ;
Hieronymus, Haley ;
Sawyers, Charles ;
Tewari, Ashutosh K. ;
Moch, Holger ;
Yoon, Ghil Suk ;
Known, Yong Chul ;
Andren, Ove ;
Fall, Katja ;
Demichelis, Francecsa ;
Mosquera, Juan Miguel ;
Robinson, Brian D. ;
Barbieri, Christopher E. ;
Rubin, Mark A. .
NEOPLASIA, 2014, 16 (01) :14-U34
[6]   Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate [J].
Carver, Brett S. ;
Tran, Jennifer ;
Gopalan, Anuradha ;
Chen, Zhenbang ;
Shaikh, Safa ;
Carracedo, Arkaitz ;
Alimonti, Andrea ;
Nardella, Caterina ;
Varmeh, Shohreh ;
Scardino, Peter T. ;
Cordon-Cardo, Carlos ;
Gerald, William ;
Pandolfi, Pier Paolo .
NATURE GENETICS, 2009, 41 (05) :619-624
[7]   Cyclin-dependent kinases regulate epigenetic gene silencing through phosphorylation of EZH2 [J].
Chen, Shuai ;
Bohrer, Laura R. ;
Rai, Aswathy N. ;
Pan, Yunqian ;
Gan, Lu ;
Zhou, Xianzheng ;
Bagchi, Anindya ;
Simon, Jeffrey A. ;
Huang, Haojie .
NATURE CELL BIOLOGY, 2010, 12 (11) :1108-U118
[8]   ETS factors reprogram the androgen receptor cistrome and prime prostate tumorigenesis in response to PTEN loss [J].
Chen, Yu ;
Chi, Ping ;
Rockowitz, Shira ;
Iaquinta, Phillip J. ;
Shamu, Tambudzai ;
Shukla, Shipra ;
Gao, Dong ;
Sirota, Inna ;
Carver, Brett S. ;
Wongvipat, John ;
Scher, Howard I. ;
Zheng, Deyou ;
Sawyers, Charles L. .
NATURE MEDICINE, 2013, 19 (08) :1023-+
[9]   Role of the TMPRSS2-ERG gene fusion in prostate cancer [J].
Chinnaiyan, Arul M. .
NEOPLASIA, 2008, 10 (02) :177-U23
[10]   Diversity of TMPRSS2-ERG fusion transcripts in the human prostate [J].
Clark, J. ;
Merson, S. ;
Jhavar, S. ;
Flohr, P. ;
Edwards, S. ;
Foster, C. S. ;
Eeles, R. ;
Martin, F. L. ;
Phillips, D. H. ;
Crundwell, M. ;
Christmas, T. ;
Thompson, A. ;
Fisher, C. ;
Kovacs, G. ;
Cooper, C. S. .
ONCOGENE, 2007, 26 (18) :2667-2673